{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:08:55Z","timestamp":1793362135468,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Can J Anesth\/J Can Anesth"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s12630-020-01812-3","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T16:03:32Z","timestamp":1600445012000},"page":"1789-1797","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Sugammadex use in patients with end-stage renal disease: a historical cohort study","Utilisation de sugammadex chez les patients atteints d\u2019insuffisance r\u00e9nale terminale : une \u00e9tude de cohorte historique"],"prefix":"10.1007","volume":"67","author":[{"given":"Stephania","family":"Paredes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven B.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Ivan E.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9389-6413","authenticated-orcid":false,"given":"J. Ross","family":"Renew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,18]]},"reference":[{"key":"1812_CR1","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/1521-3773(20020118)41:2<265::AID-ANIE265>3.0.CO;2-Q","volume":"41","author":"A Bom","year":"2002","unstructured":"Bom A, Bradley M, Cameron K, et al. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl 2002; 41: 266-70.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1812_CR2","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/bja\/aet586","volume":"114","author":"IF Panhuizen","year":"2015","unstructured":"Panhuizen IF, Gold SJ, Buerkle C, et al. Efficacy, safety and pharmacokinetics of sugammadex 4 mg kg\u22121 for reversal of deep neuromuscular blockade in patients with severe renal impairment. Br J Anaesth 2015; 114: 777-84.","journal-title":"Br J Anaesth"},{"key":"1812_CR3","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/00000542-200309000-00018","volume":"99","author":"O Epemolu","year":"2003","unstructured":"Epemolu O, Bom A, Hope F, Mason R. Reversal of neuromuscular blockade and simultaneous increase in plasma rocuronium concentration after the intravenous infusion of the novel reversal agent Org 25969. Anesthesiology 2003; 99: 632-7.","journal-title":"Anesthesiology"},{"key":"1812_CR4","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1097\/00000542-200510000-00007","volume":"103","author":"F Gijsenbergh","year":"2005","unstructured":"Gijsenbergh F, Ramael S, Houwing N, van Iersel T. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology 2005; 103: 695-703.","journal-title":"Anesthesiology"},{"key":"1812_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/bja\/aep340","volume":"104","author":"LM Staals","year":"2010","unstructured":"Staals LM, Snoeck MM, Driessen JJ, et al. Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study. Br J Anaesth 2010; 104: 31-9.","journal-title":"Br J Anaesth"},{"key":"1812_CR6","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1097\/01.anes.0000265152.78943.74","volume":"106","author":"HJ Sparr","year":"2007","unstructured":"Sparr HJ, Vermeyen KM, Beaufort AM, et al. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics. Anesthesiology 2007; 106: 935-43.","journal-title":"Anesthesiology"},{"key":"1812_CR7","unstructured":"Food and Drug Administration. BRIDION\u00ae (sugammadex) Injection, for intravenous use - 2015. Available from URL: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/022225lbl.pdf (accessed July 2020)."},{"key":"1812_CR8","doi-asserted-by":"crossref","unstructured":"Hristovska AM, Duch P, Allingstrup M, Afshari A. The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A Cochrane systematic review with meta-analysis and trial sequential analysis. Anaesthesia 2018; 73: 631-41.","DOI":"10.1111\/anae.14160"},{"key":"1812_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jclinane.2016.06.018","volume":"35","author":"M Carron","year":"2016","unstructured":"Carron M, Zarantonello F, Tellaroli P, Ori C. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials. J Clin Anesth 2016; 35: 1-12.","journal-title":"J Clin Anesth"},{"key":"1812_CR10","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/EJA.0000000000000312","volume":"32","author":"CM de Souza","year":"2015","unstructured":"de Souza CM, Tardelli MA, Tedesco H, et al. Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease: a comparative prospective clinical trial. Eur J Anaesthesiol 2015; 32: 681-6.","journal-title":"Eur J Anaesthesiol"},{"key":"1812_CR11","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/anae.14914","volume":"75","author":"DR Adams","year":"2020","unstructured":"Adams DR, Tollinche LE, Yeoh CB, et al. Short-term safety and effectiveness of sugammadex for surgical patients with end-stage renal disease: a two-centre retrospective study. Anaesthesia 2020; 75: 348-52.","journal-title":"Anaesthesia"},{"key":"1812_CR12","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/bja\/aen216","volume":"101","author":"LM Staals","year":"2008","unstructured":"Staals LM, Snoeck MM, Driessen JJ, Flockton EA, Heeringa M, Hunter JM. Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function. Br J Anaesth 2008; 101: 492-7.","journal-title":"Br J Anaesth"},{"key":"1812_CR13","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1213\/XAA.0000000000000934","volume":"12","author":"SR Navare","year":"2019","unstructured":"Navare SR, Garcia Medina O, Prielipp RC, Weinkauf JL. Sugammadex reversal of a large subcutaneous depot of rocuronium in a dialysis patient: a case report. A A Pract 2019; 12: 375-7.","journal-title":"A A Pract"},{"key":"1812_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2012-007603","author":"S Lobaz","year":"2013","unstructured":"Lobaz S, Sammut M, Damodaran A. Sugammadex rescue following prolonged rocuronium neuromuscular blockade with \u201crecurarisation\u201d in a patient with severe renal failure. BMJ Case Rep 2013; DOI: https:\/\/doi.org\/10.1136\/bcr-2012-007603.","journal-title":"BMJ Case Rep"},{"key":"1812_CR15","first-page":"238","volume":"24","author":"K Pfaff","year":"2019","unstructured":"Pfaff K, Tumin D, Tobias JD. Sugammadex for Reversal of Neuromuscular Blockade in a Patient With Renal Failure. J Pediatr Pharmacol Ther 2019; 24: 238-41.","journal-title":"J Pediatr Pharmacol Ther"},{"key":"1812_CR16","first-page":"746","volume":"55","author":"KC Min","year":"2017","unstructured":"Min KC, Lasseter KC, Marbury TC, et al. Pharmacokinetics of sugammadex in subjects with moderate and severe renal impairment. Int J Clin Pharmacol Ther 2017; 55: 746-52.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"1812_CR17","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/bja\/aes207","volume":"109","author":"G Cammu","year":"2012","unstructured":"Cammu G, Van Vlem B, van den Heuvel M, et al. Dialysability of sugammadex and its complex with rocuronium in intensive care patients with severe renal impairment. Br J Anaesth 2012; 109: 382-90.","journal-title":"Br J Anaesth"},{"key":"1812_CR18","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1213\/ANE.0000000000002562","volume":"126","author":"Y Miyazaki","year":"2018","unstructured":"Miyazaki Y, Sunaga H, Kida K, et al. Incidence of anaphylaxis associated with sugammadex. Anesth Analg 2018; 126: 1505-8.","journal-title":"Anesth Analg"},{"key":"1812_CR19","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/00000542-197909000-00008","volume":"51","author":"R Cronnelly","year":"1979","unstructured":"Cronnelly R, Stanski DR, Miller RD, Sheiner LB, Sohn YJ. Renal function and the pharmacokinetics of neostigmine in anesthetized man. Anesthesiology 1979; 51: 222-6.","journal-title":"Anesthesiology"},{"issue":"2 Suppl 1","key":"1812_CR20","first-page":"S1","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney Foundation. K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(2 Suppl 1): S1-266.","journal-title":"Am J Kidney Dis"},{"key":"1812_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform 2019; DOI: https:\/\/doi.org\/10.1016\/j.jbi.2019.103208.","journal-title":"J Biomed Inform"},{"key":"1812_CR22","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.bja.2018.05.056","volume":"121","author":"KC Min","year":"2018","unstructured":"Min KC, Bondiskey P, Schulz V, et al. Hypersensitivity incidence after sugammadex administration in healthy subjects: a\u00a0randomised controlled trial. Br J Anaesth 2018; 121: 749-57.","journal-title":"Br J Anaesth"},{"key":"1812_CR23","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s00540-015-2105-x","volume":"30","author":"T Takazawa","year":"2016","unstructured":"Takazawa T, Mitsuhata H, Mertes PM. Sugammadex and rocuronium-induced anaphylaxis. J Anesth 2016; 30: 290-7.","journal-title":"J Anesth"},{"key":"1812_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2253-14-92","author":"T Takazawa","year":"2014","unstructured":"Takazawa T, Tomita Y, Yoshida N, et al. Three suspected cases of sugammadex-induced anaphylactic shock. BMC Anesthesiol 2014; DOI: https:\/\/doi.org\/10.1186\/1471-2253-14-92.","journal-title":"BMC Anesthesiol"},{"key":"1812_CR25","doi-asserted-by":"publisher","first-page":"413","DOI":"10.4097\/kjae.2016.69.4.413","volume":"69","author":"JH Yoo","year":"2016","unstructured":"Yoo JH, Kim SI, Ok SY, et al. Suspected anaphylactic reaction associated with sugammadex: a case report. Korean J Anesthesiol 2016; 69: 413-6.","journal-title":"Korean J Anesthesiol"},{"key":"1812_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/ALN.0b013e318190bc32","volume":"110","author":"BA Ploeger","year":"2009","unstructured":"Ploeger BA, Smeets J, Strougo A, et al. Pharmacokinetic\u2013pharmacodynamic model for the reversal of neuromuscular blockade by sugammadex. Anesthesiology 2009; 110: 95-105.","journal-title":"Anesthesiology"},{"key":"1812_CR27","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1213\/01.ane.0000244594.63318.fc","volume":"104","author":"M Naguib","year":"2007","unstructured":"Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesth Analg 2007; 104: 575-81.","journal-title":"Anesth Analg"},{"key":"1812_CR28","doi-asserted-by":"crossref","unstructured":"Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg 2010; 111: 120-8.","DOI":"10.1213\/ANE.0b013e3181da832d"},{"key":"1812_CR29","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.jvs.2008.07.006","volume":"48","author":"AN Sidawy","year":"2008","unstructured":"Sidawy AN, Aidinian G, Johnson ON 3rd, White PW, DeZee KJ, Henderson WG. Effect of chronic renal insufficiency on outcomes of carotid endarterectomy. J Vasc Surg 2008; 48: 1423-30.","journal-title":"J Vasc Surg"},{"key":"1812_CR30","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1001\/archinte.1994.00420150030004","volume":"154","author":"PS Kellerman","year":"1994","unstructured":"Kellerman PS. Perioperative care of the renal patient. Arch Intern Med 1994; 154: 1674-88.","journal-title":"Arch Intern Med"},{"key":"1812_CR31","first-page":"479","volume":"31","author":"S Schreiber","year":"1995","unstructured":"Schreiber S, Korzets A, Powsner E, Wolloch Y. Surgery in chronic dialysis patients. Isr J Med Sci 1995; 31: 479-83.","journal-title":"Isr J Med Sci"},{"key":"1812_CR32","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s11605-013-2390-3","volume":"18","author":"JM Cloyd","year":"2014","unstructured":"Cloyd JM, Ma Y, Morton JM, Kurella Tamura M, Poultsides GA, Visser BC. Does chronic kidney disease affect outcomes after major abdominal surgery? Results from the National Surgical Quality Improvement Program. J Gastrointest Surg 2014; 18: 605-12.","journal-title":"J Gastrointest Surg"},{"key":"1812_CR33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0003-4975(99)01133-9","volume":"69","author":"M Horst","year":"2000","unstructured":"Horst M, Mehlhorn U, Hoerstrup SP, Suedkamp M, de Vivie ER. Cardiac surgery in patients with end-stage renal disease: 10-year experience. Ann Thorac Surg 2000; 69: 96-101.","journal-title":"Ann Thorac Surg"},{"key":"1812_CR34","first-page":"15","volume":"102","author":"B Borlase","year":"1987","unstructured":"Borlase B, Simon JS, Hermann G. Abdominal surgery in patients undergoing chronic hemodialysis. Surgery 1987; 102: 15-8.","journal-title":"Surgery"},{"key":"1812_CR35","first-page":"1471","volume":"66","author":"M Krishnan","year":"2002","unstructured":"Krishnan M. Preoperative care of patients with kidney disease. Am Fam Physician 2002; 66: 1471-6.","journal-title":"Am Fam Physician"},{"key":"1812_CR36","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/ALN.0b013e31818a3fee","volume":"109","author":"RK Jones","year":"2008","unstructured":"Jones RK, Caldwell JE, Brull SJ, Soto RG. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. Anesthesiology 2008; 109: 816-24.","journal-title":"Anesthesiology"},{"key":"1812_CR37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1213\/ANE.0000000000002670","volume":"127","author":"M Naguib","year":"2018","unstructured":"Naguib M, Brull SJ, Kopman AF, et al. Consensus statement on perioperative use of neuromuscular monitoring. Anesth Analg 2018; 127: 71-80.","journal-title":"Anesth Analg"}],"container-title":["Canadian Journal of Anesthesia\/Journal canadien d'anesth\u00e9sie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-020-01812-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12630-020-01812-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-020-01812-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T01:19:01Z","timestamp":1631927941000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12630-020-01812-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,18]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1812"],"URL":"https:\/\/doi.org\/10.1007\/s12630-020-01812-3","relation":{},"ISSN":["0832-610X","1496-8975"],"issn-type":[{"value":"0832-610X","type":"print"},{"value":"1496-8975","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,18]]},"assertion":[{"value":"27 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}